Evidence map›Paper›PMID 35980496›Full record

ArticleMycopathologia2023

Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling.

Mahdi Abastabar, Maryam Babaei, Rasoul Mohammadi, Reza Valadan, Javad Javidnia, Arezoo Zaedi, Seyed Reza Aghili, Iman Haghani, Shaghayegh Khojasteh, Ali Reazaei-Matehkolaei and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Dermatophytosis: An Update on Global Epidemiology.Journal of fungi (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Terbinafine Resistance inJournal of clinical medicine · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Predominance ofCurrent medical mycology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 1 country.

Mahdi AbastabarDepartment of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Maryam BabaeiDepartment of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Rasoul MohammadiDepartment of Medical Parasitology and Mycology, School of Medicine, Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Reza ValadanMolecular and Cell Biology Research Center (MCBRC), Mazandaran University of Medical Sciences, Sari, Iran.
Javad JavidniaDepartment of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Arezoo ZaediDepartment of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Seyed Reza AghiliDepartment of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Iman HaghaniDepartment of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Shaghayegh KhojastehDepartment of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Ali Reazaei-MatehkolaeiInfectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Neda KiasatInfectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Kambiz Kamyab HesariDepartment of Dermatopathology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Zeinab GhasemiDepartment of Medical Mycology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Maryam AzishDepartment of Parasitology and Medical Mycology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
Hossein ZarrinfarAllergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mojtaba Taghizadeh-ArmakiDepartment of Parasitology and Mycology, Infectious Diseases and Tropical Medicine Research Center, Health Research Center, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Naser KeikhaMedical Laboratory Sciences Department, Infectious Diseases and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.
Mahboobeh KharaziDepartment of Medical Parasitology and Mycology, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Hossein KhodadadiDepartment of Medical Parasitology and Mycology, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad Taghi HedayatiDepartment of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. hedayatimt@gmail.com.
Tahereh ShokohiDepartment of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. shokohi.tahereh@gmail.com.ORCID http://orcid.org/0000-0003-3094-8436
Mazandaran University of Medical Sciences · IRAhvaz Jundishapur University of Medical Sciences · IRRazi Hospital · IRShiraz University of Medical Sciences · IRBabol University of Medical Sciences · IRDezful University of Medical Sciences · IRIsfahan University of Medical Sciences · IRMashhad University of Medical Sciences · IRZahedan University of Medical Sciences · IR

Funding

Invasive Fungi Research Center, Mazandaran University of Medical Sciences 8470
6 · The paper itself

Abstract

backgroundThe data on the epidemiological and antifungal susceptibility profile of tinea capitis (TC) in Iran has not been updated in recent decades. This report presents the Iranian epidemiological and drug susceptibility data regarding the distribution of dermatophytes species isolated by six national mycology centers for a period of one year (2020-2021). MATERIAL AND

methodsA total of 2100 clinical samples from individuals suspeted to TC were subjected to mycological analysis of direct microscopy and culture. For definite species identification, the culture isolates were additionally subjected to PCR-RFLP and PCR-sequencing of the ITS ribosomal DNA (ITS-rDNA) region. Antifungal susceptibility profiles for eight common antifungal drugs were determined by CLSI M38-A3 guidelines. The SQLE gene was partially amplified and sequenced in two terbinafine-resistant and two susceptible T. mentagrophytes isolates to elucidate probable substitutions involved in resistance.

resultsTC (n = 94) was diagnosed in 75 children (79.8%) and 19 adults (20.2%) by direct microscopy and culture. Frequency of TC was significantly more among males (66 males = 70.2% vs 28 females = 29.8%). The prevalent age group affected was 5-9 years (39.36%). Thirty-two (34.04%) T. mentagrophytes, 27 (28.7%) T. tonsurans, 14 (14.9%) M. canis, 13 (13.8%) T. violaceum, 5 (5.32%) T. indotineae, 2 (2.1%) T. benhamiae, and 1 (1.1%) T. schoenleinii were identified as the causative agents. MIC values of isolates showed susceptibility to all antifungal agents, except for fluconazole and griseofulvin with GM MIC of 11.91 μg/ml and 2.01 μg/ml, respectively. Terbinafine exhibited more activity against isolates, with GM MIC 0.084 μg/ml followed by ketoconazole (0.100 μg/ml), econazole (0.107 μg/ml), itraconazole (0.133 μg/ml), butenafine (0.142 μg/ml), and miconazole (0.325 μg/ml). Two resistant T. mentagrophytes isolates harbored missense mutations in SQLE gene, corresponding to amino acid substitution F397L. Remarkably, one unique mutation, C1255T, in the SQLE sequence of two terbinafine-susceptible T. mentagrophytes strains leading to a change of leucine at the 419th position to phenylalanine (L419F) was detected.

conclusionsT. mentagrophytes, T. tonsurans, and M. canis remained the main agents of TC in Iran, however less known species such as T. indotinea and T. benhamiae are emerging as new ones. Terbinafine could still be the appropriate choice for the treatment of diverse forms of TC.

Indexed as

ArthrodermataceaeTineaTinea CapitisAdultAntifungal AgentsChildChild, PreschoolDrug Resistance, FungalFemaleHumansIranMaleMicrobial Sensitivity TestsMutationTerbinafineTrichophytonAntifungal AgentsTerbinafineAntifungal susceptibilityTerbinafine-resistantTinea capitisT. mentagrophytesT. schoenleinii

Identifiers

PMID35980496
OpenAlexW4293149894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.